Concepedia

Early results from a phase I study on orally administered tris(8-quinolinolato)gallium(III) (FFC11, KP46) in patients with solid tumors ? a CESAR study (Central European Society for Anticancer Drug Research ? EW

Ralf‐Dieter Hofheinz, C. Dittrich, Michael A. Jakupec, A. Drescher, Ulrich Jaehde, Margit Gneist, Nikolai Graf von Keyserlingk, Bernhard K. Keppler, Andreas Hochhaus

International Journal of Clinical Pharmacology and Therapeutics · 2005 · 63 citations · 0 references

DOI

Concepts